Clariance ErYs Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorClariance
About this trial
International, prospective, single arm, multicenter and observational Post-Market Clinical Follow-up (PMCF).
The overall objective of this study is to collect preoperative, intraoperative and postoperative (at 9 weeks, 6 months, 1 year and 2 years) data on the clinical complications and functional outcomes of the study devices to demonstrate safety and performance in a real-world setting.
The primary objective is to demonstrate that the use of the study devices is safe.
The secondary objective is to demonstrate that the use of the study devices decreases the pain, and improves the quality of life and the daily activities of the subjects.
Eligibility criteria
Qualifiers
Considered as adult in the respective geography (18 years old or older for France and 21 years old or older for United-States).
Indicated for treatment with one or more commercially available sponsor spine device included into the study.
For France only, affiliated with or beneficiary of a social security scheme.
Disqualifiers
Subjects who are not able to comply with the study procedures based on the judgment of the investigator (e.g., inability to comprehend study related questions, inability to keep scheduled assessment times).
Subjects who are considered as vulnerable: minor, pregnant woman or people under legal protection (guardianship or curatorship).
Contraindicated for spine surgery utilizing a commercially available sponsor spine device.
Trial design
Treatments tested in this trial
- Spine surgery
Treatment groups
760 Participants
are divided into 11 treatment groups11
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Source ClinicalTrials.gov